Microsurgery

ZEISS showcasing wider range of quality solutions in different pavilions at IMTS

Retrieved on: 
Wednesday, September 7, 2022
Quality, Technology, Software maintenance, 3D, Smart products, Program, Research, Ophthalmology, National Institute of Metrology Standardization and Industrial Quality, Solution, Coffee, IMTS, Software, CT, Consumer, Health, Plastic, Science, Aircraft, Investment, Student, Multimedia, ZEISS, Carl-Zeiss-Stiftung, Conference, Microsurgery, Foundation, LLC, Challenge, Carl Zeiss AG, Knowledge, PM, Industry, Telescopic sight, Medical device

The technology solutions will be featured in four different booths, in three different areas of IMTS, including the Quality and Additive Pavilions, and the Smartforce Student Summit.

Key Points: 
  • The technology solutions will be featured in four different booths, in three different areas of IMTS, including the Quality and Additive Pavilions, and the Smartforce Student Summit.
  • At the main booth, #135502 in the Quality Pavilion, ZEISS will present technologies and application highlights in the areas of ZEISS eMobility Solutions, ZEISS Medical Industry Solutions, ZEISS Aerospace Solutions, and more.
  • In addition, ZEISS Industrial Quality Solutions offers a broad global spectrum of customer services with ZEISS Quality Excellence Centers close to its customers.
  • ZEISS Industrial Quality Solutions is part of the Industrial Quality & Research segment.

San Antonio Breast Center Welcomes Newest Breast Reconstruction Specialist to the Team

Retrieved on: 
Wednesday, August 31, 2022
Breast reconstruction, University, Breast cancer, Medical Center, SAN, Albany Medical College, Albany Medical Center, Education, University of Pennsylvania, Siena College, Medicine, Health, Biology, Microsurgery, Mastectomy, Knowledge, Achievement Medal, Patient, Dentistry, Medical imaging

SAN ANTONIO , Aug. 31, 2022  /PRNewswire-PRWeb/ -- To expand access to advanced breast reconstruction techniques and patient care, PRMA Plastic Surgery is excited to welcome plastic surgeon Dr. Lauren Whipple to the team.

Key Points: 
  • SAN ANTONIO, Aug. 31, 2022 /PRNewswire-PRWeb/ -- To expand access to advanced breast reconstruction techniques and patient care, PRMA Plastic Surgery is excited to welcome plastic surgeon Dr. Lauren Whipple to the team.
  • PRMA Plastic Surgery | Center for Advanced Breast Reconstruction opened its doors to serve the local San Antonio, Texas breast cancer community over 25 years ago.
  • Since welcoming its first patient in 1994, PRMA has expanded to be one of the top breast reconstruction centers in the world.
  • Dr. Whipple is passionate about women's health and access to education and care regarding breast reconstruction after breast cancer.

ZEISS Integrated Workflow Solutions are Creating the Digital Transformation in Healthcare

Retrieved on: 
Tuesday, August 30, 2022
Patient, HIV disease progression rates, European Society for Medical Oncology, ISIN, Safety, Ophthalmology, Application, MDAX, Artificial intelligence, American Academy, Doctor of Philosophy, Solution, TecDAX, Carin, MIT Center for Digital Business, Eye, Carl Zeiss Meditec, Intelligence, Data management, Cataract, Workflow, Quality of life, Multimedia, ZEISS, Health technology, Annual general meeting, Leadership, AAO, Company, Therapy, Microsurgery, Center, Conference, Group, Efficiency, American Academy of Ophthalmology, Carl Zeiss AG, Environment, Health, Medical imaging, Pharmaceutical industry, Research, MD

JENA, Germany and DUBLIN, Aug. 30, 2022 /PRNewswire/ -- ZEISS Medical Technology continues to build on its leadership in digital solutions by exploring new ways to advance the future of transformative care in ophthalmology. At ZEISS Innovation Week, September 6-8, 2022, ZEISS Medical Technology will host leading experts in ophthalmology to share their personal experiences of how the power of integrated workflow solutions, data management and a range of new software applications are enabling improved efficiencies and optimization of patient care.

Key Points: 
  • "As a leader in digital solutions, ZEISS is setting the standard for new ways to manage care at scale.
  • Using data insights and integrated workflow solutions with artificial intelligence adds value in managing disease progression and the optimization of clinical practices," said Euan S. Thomson, PhD, President of Ophthalmic Devices and Head of Digital Business at Carl Zeiss Meditec, Inc. "We continue to focus on the development of digital solutions creating the roadmap needed for improved care."
  • The Company supplies innovative technologies and application-oriented solutions designed to help doctors improve the quality of life of their patients.
  • 59 percent are held by Carl Zeiss AG, one of the world's leading groups in the optical and optoelectronic industries.

ZEISS Integrated Workflow Solutions are Creating the Digital Transformation in Healthcare

Retrieved on: 
Tuesday, August 30, 2022
Patient, HIV disease progression rates, European Society for Medical Oncology, ISIN, Safety, Ophthalmology, Application, MDAX, Artificial intelligence, American Academy, Doctor of Philosophy, Solution, TecDAX, Carin, MIT Center for Digital Business, Eye, Carl Zeiss Meditec, Intelligence, Data management, Cataract, Workflow, Quality of life, ZEISS, Health technology, Annual general meeting, Leadership, AAO, Company, Therapy, Microsurgery, Center, Conference, Group, Efficiency, American Academy of Ophthalmology, Carl Zeiss AG, Environment, Health, Medical imaging, Pharmaceutical industry, Research, MD

JENA, Germany and DUBLIN, Aug. 30, 2022 /PRNewswire/ -- ZEISS Medical Technology continues to build on its leadership in digital solutions by exploring new ways to advance the future of transformative care in ophthalmology. At ZEISS Innovation Week, September 6-8, 2022, ZEISS Medical Technology will host leading experts in ophthalmology to share their personal experiences of how the power of integrated workflow solutions, data management and a range of new software applications are enabling improved efficiencies and optimization of patient care.

Key Points: 
  • "As a leader in digital solutions, ZEISS is setting the standard for new ways to manage care at scale.
  • Using data insights and integrated workflow solutions with artificial intelligence adds value in managing disease progression and the optimization of clinical practices," said Euan S. Thomson, PhD, President of Ophthalmic Devices and Head of Digital Business at Carl Zeiss Meditec, Inc. "We continue to focus on the development of digital solutions creating the roadmap needed for improved care."
  • The Company supplies innovative technologies and application-oriented solutions designed to help doctors improve the quality of life of their patients.
  • 59 percent are held by Carl Zeiss AG, one of the world's leading groups in the optical and optoelectronic industries.

Global Microscope Market to Reach $20.4 Billion by 2030

Retrieved on: 
Friday, August 19, 2022
Electron, Diagnosis, Technology, Growth, Cancer, Spine, Investment, Research, COVID-19, Microscopy, Scanning probe microscopy, CAGR, APAC, Nanotechnology, Semiconductor, Association, Microsurgery, USD, Adoption, Microscope, Renewable energy

The global microscope market size is expected to reach USD 20.4 billion by 2030., expanding at a CAGR of 7.97% over the forecast period.

Key Points: 
  • The global microscope market size is expected to reach USD 20.4 billion by 2030., expanding at a CAGR of 7.97% over the forecast period.
  • High demand from the healthcare sector and the rapidly growing semiconductor industry are among the key factors boosting the market growth.
  • The life science application segment led the market in 2021 due to wide product applications in the diagnosis of diseases.
  • Asia Pacific dominated the market in 2021and is estimated to record the fastest CAGR from 2022 to 2030.

Global Microscope Market Report 2022: Adoption and Rising Investments in the Development of Microscopes by Precision Manufacturing Industries to Drive Growth - ResearchAndMarkets.com

Retrieved on: 
Wednesday, August 17, 2022
Semiconductor, Technology, Nanotechnology, Other Science, Research, Science, Hardware, Electron, Diagnosis, Technology, Growth, Cancer, Spine, Investment, Research, COVID-19, Microscopy, CAGR, APAC, Nanotechnology, Semiconductor, Association, Microsurgery, USD, Adoption, Microscope, Renewable energy

The global microscope market size is expected to reach USD 20.4 billion by 2030, expanding at a CAGR of 7.97% over the forecast period.

Key Points: 
  • The global microscope market size is expected to reach USD 20.4 billion by 2030, expanding at a CAGR of 7.97% over the forecast period.
  • High demand from the healthcare sector and the rapidly growing semiconductor industry are among the key factors boosting the market growth.
  • The growing adoption and rising investments in the development of microscopes by precision manufacturing industries are expected to drive market growth.
  • The life science application segment led the market in 2021 due to wide product applications in the diagnosis of diseases.

DGAP-News: Carl Zeiss Meditec achieves further significant growth in revenue and order intake after nine months of 2021/22

Retrieved on: 
Friday, August 5, 2022
EBIT, Growth, EMEA, Microsurgery, SBU, Marketing, Orders, COVID-19, Tax, APAC, Development, Pharmaceutical industry, Animal, Research

Carl Zeiss Meditec generated revenue of 1,332.9m in the first nine months of fiscal year 2021/22 (prior year: 1,198.2m), corresponding to an increase of 11.2% (adjusted for currency effects: +9.8%) compared with the same period of the prior year.

Key Points: 
  • Carl Zeiss Meditec generated revenue of 1,332.9m in the first nine months of fiscal year 2021/22 (prior year: 1,198.2m), corresponding to an increase of 11.2% (adjusted for currency effects: +9.8%) compared with the same period of the prior year.
  • Order intake increased at a much higher rate than revenue, rising 36.0% to 1,750.5m (prior year: 1,287.6m).
  • I am therefore highly satisfied with the very solid revenue growth and the even stronger order intake.
  • Revenue growth, as well as in particular the increasing share of recurring revenue and favorable currency effects, had a positive impact on operating result.

Dr. Sam Jejurikar Honored Among The Best Plastic Surgeons in America

Retrieved on: 
Wednesday, August 3, 2022
Politics, Plastic surgery, Publication, Skin, Culture, Medicine, Patient, American Medical Association, Education, American Society of Plastic Surgeons, American Board of Plastic Surgery, Health, Industry, Tissue, Society, Microsurgery, Technology, Face, Solution, Plastic, Aesthetic Plastic Surgery, National Society of Certified Healthcare Business Consultants, American Society for Aesthetic Plastic Surgery, Master of Business Administration, Medical missions, MBA, D Magazine, American Board of Commissioners for Foreign Missions, Rhinoplasty, Surgeon, University, Breast, Dentistry, Newsweek

DALLAS, Aug. 3, 2022 /PRNewswire/ -- Upon the release of Newsweek's rankings of America's Best Plastic Surgeons, Dr. Sam Jejurikar of Dallas, Texas, was honored as a top plastic surgeon. Dr. Sam Jejurikar stood out amongst the competition from across the country after a thorough analysis of his track record as an outstanding practitioner.

Key Points: 
  • DALLAS, Aug. 3, 2022 /PRNewswire/ --Upon the release of Newsweek's rankings of America's Best Plastic Surgeons, Dr. Sam Jejurikar of Dallas, Texas, was honored as a top plastic surgeon.
  • Board-certified by the American Board of Plastic Surgery, Dr. Sam Jejurikar has been practicing medicine since 1997.
  • Board-certified plastic surgeon Dr. Sam Jejurikar serves patients in Dallas, Plano, and beyond via the Dallas Plastic Surgery Institute.
  • Dr. Jejurikar is an active member of the American Society of Plastic Surgeons, American Society for Aesthetic Plastic Surgery, Dallas Society of Plastic Surgeons, American Medical Association, and a diplomat of the American Board of Plastic Surgery.

ZEISS Microscopy Showcases New Interactive Display Wall at Microscopy and Microanalysis (M&M) 2022 Conference

Retrieved on: 
Monday, July 25, 2022
Carl-Zeiss-Stiftung, Investment, Education, Foundation, Industry, Research, Carl Zeiss AG, Solution, Ophthalmology, Multimedia, Technology, Smart products, National Institute of Metrology Standardization and Industrial Quality, Science, Light, Microsurgery, Health, Consumer, Telescopic sight, Microscope, ZEISS

WHITE PLAINS, N.Y., July 25, 2022 /PRNewswire/ -- ZEISS is installing a new interactive display wall that celebrates researchers' breakthroughs at M&M 2022, in Portland, OR, booth 1018, from July 31 to August 4. The wall features an interactive touch screen display that highlights multiple researchers from around the world and their breakthroughs in high visual detail.

Key Points: 
  • The name ZEISS is also synonymous with the world's leading lithography optics, which are used by the chip industry to manufacture semiconductor components.
  • There is global demand for trendsetting ZEISS brand products such as eyeglass lenses, camera lenses and binoculars.
  • ZEISS Research Microscopy Solutions is the world's only one-stop manufacturer of light, electron, X-ray and ion microscope systems and offers solutions for correlative microscopy.
  • ZEISS Research Microscopy Solutions is part of the Industrial Quality & Research segment.

Medical Microinstruments Secures $75M to Advance Robotic Microsurgery

Retrieved on: 
Wednesday, July 20, 2022
Surgery, Medical Devices, Health, Robotics, Technology, Regulation of tobacco by the U.S. Food and Drug Administration, Instrument, Neurosurgery, Surgeon, Center, Food, Health, CEO, Research, Platform supply vessel, Trauma, Hand, Board, Therapy, Cancer, ZEUS robotic surgical system, RA, Artery, Technology, Vein, Tremor, Patient, Robotics, Center of excellence, Comau, Microsurgery, MMI, IDE, Growth, Medical device, Management, Dentistry, Biostar, MD, Atlantic Ocean

Medical Microinstruments, Inc. (MMI) , a robotics company dedicated to improving clinical outcomes for patients undergoing microsurgery, today announced it has raised $75 million in Series B financing.

Key Points: 
  • Medical Microinstruments, Inc. (MMI) , a robotics company dedicated to improving clinical outcomes for patients undergoing microsurgery, today announced it has raised $75 million in Series B financing.
  • Robotic microsurgery has enormous potential to both improve the standard of care for patients and help surgeons manage procedures that require delicate precision, said Ms. Cameron.
  • Medical Microinstruments, Inc. (MMI) was founded in 2015 near Pisa, Italy to enhance surgical performance through the development of a robotic system that enables surgeons to achieve better outcomes in microsurgery.
  • The Symani Surgical System combines proprietary innovations including the worlds smallest wristed microinstruments as well as tremor-reducing and motion-scaling technologies.